| Pfizer AG - Tazobac 2,25 g, Pulver zur Herstellung einer Infusionslösung | | 50991 | | 05 | | Tazobac 2,25 g | | Pulver zur Herstellung einer Infusionslösung | | J01CR05 | | Piperacillin and Beta-Lactamase Inhibitor | | 01.12.2006 | | |
| | Composition | | Praeparatio cryodesiccata: piperacillinum 2 g ut piperacillinum natricum, tazobactamum 0.25 g ut tazobactamum natricum, natrii citras anhydricus, acidum citricum, dinatrii edetas, pro vitro corresp. natrium 130.39 mg. | | Packungsbestandteile | | Praeparatio cryodesiccata: | | Lyophilisate | | | | | | Active Agent | Dose |
|---|
| Piperacilline | 2 g | | Tazobactame | 0.25 g |
| | | | Inactive agents |
|---|
| Citric Acid | | Dinatrii Edetas | | Natrii Citras Anhydricus |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 061 | 12 Flasche(n) | PR | PR | A | | Yes |
|
|
